Loading company…
ID 445396884 · FY 2018–2024 · 7 years
მისი ძირითადი საქმიანობაა ინტერვენციული კარდიოლოგიური სახარჯი მასალების რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 0 | 53 | 693 | 250 | 39 | 605 | 55 | +0.8% |
| Net Change in Cash (before FX) | 0 | 53 | 693 | 250 | 39 | 605 | 55 | +0.8% |
| Net Change in Cash (incl. FX) | 0 | 53 | 693 | 250 | 39 | 605 | 55 | +0.8% |
| Cash at Beginning of Year | 288 | 233 | 286 | 979 | 1,229 | 1,267 | 1,872 | +36.6% |
| Cash at End of Year | 288 | 286 | 979 | 1,229 | 1,267 | 1,872 | 1,927 | +37.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sector, ranked by how close their latest revenue is to this one — not a curated comp set.